Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 69,579
Sort by:

Integrin Alpha 2b (GPalpha IIb or Platelet Membrane Glycoprotein IIb or CD41 or ITGA2B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Integrin Alpha 2b (GPalpha IIb or Platelet Membrane Glycoprotein IIb or CD41 or ITGA2B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY I...

May 2022 36 pages

Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Integrin Alpha V (...

May 2022 67 pages

Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type an...

May 2022 48 pages

Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Integrin Beta 3 (P...

May 2022 57 pages

Integrin Beta 5 (ITGB5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Integrin Beta 5 (ITGB5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Integrin Beta 5 (ITGB5) Drugs in Development by Therapy Areas and...

May 2022 35 pages

Integrin Beta 8 (ITGB8) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Integrin Beta 8 (ITGB8) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Integrin Beta 8 (ITGB8) Drugs in Development by Therapy Areas and...

May 2022 37 pages

Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Inte...

May 2022 39 pages

Interferon Alpha-Beta Receptor 1 (Cytokine Receptor Class II Member 1 or Cytokine Receptor Family 2 Member 1 or Type I Interferon Receptor 1 or IFNAR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interferon Alpha-Beta Receptor 1 (Cytokine Receptor Class II Member 1 or Cytokine Receptor Family 2 Member 1 or Type I Interferon Receptor 1 or IFNAR1) Drugs in Development by Therapy Areas and Indica...

May 2022 82 pages

Interferon Alpha-Beta Receptor 2 (Interferon Alpha Binding Protein or Type I Interferon Receptor 2 or IFNAR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interferon Alpha-Beta Receptor 2 (Interferon Alpha Binding Protein or Type I Interferon Receptor 2 or IFNAR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and...

May 2022 72 pages

Interferon Alpha (IFNA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interferon Alpha (IFNA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interferon Alpha (IFNA) Drugs in Development by Therapy Areas and...

May 2022 41 pages

Interferon Beta (Fibroblast Interferon or IFNB or IFNB1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interferon Beta (Fibroblast Interferon or IFNB or IFNB1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interferon Beta (Fibroblast Inte...

May 2022 36 pages

Interferon Gamma (Immune Interferon or IFNG) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interferon Gamma (Immune Interferon or IFNG) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interferon Gamma (Immune Interferon or IFNG)...

May 2022 37 pages

Interferon Gamma Receptor 1 (CDw119 or CD119 or IFNGR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interferon Gamma Receptor 1 (CDw119 or CD119 or IFNGR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interferon Gamma Receptor 1 (CDw1...

May 2022 35 pages

Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 1 Alpha (IL 1 Alp...

May 2022 40 pages

Interleukin 1 Beta (IL 1 Beta or Catabolin or IL1B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 1 Beta (IL 1 Beta or Catabolin or IL1B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 1 Beta (IL 1 Beta or Cata...

May 2022 56 pages

Interleukin 1 Receptor Accessory Protein (Interleukin 1 Receptor 3 or IL1R3 or IL1RAP) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 1 Receptor Accessory Protein (Interleukin 1 Receptor 3 or IL1R3 or IL1RAP) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY In...

May 2022 38 pages

Interleukin 1 Receptor (IL1R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 1 Receptor (IL1R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 1 Receptor (IL1R) Drugs in Development by Thera...

May 2022 73 pages

Interleukin 1 Receptor Like 2 (IL 36 Receptor or Interleukin 1 Receptor Related Protein 2 or IL1RL2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 1 Receptor Like 2 (IL 36 Receptor or Interleukin 1 Receptor Related Protein 2 or IL1RL2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Play...

May 2022 38 pages

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 10 (Cyt...

May 2022 49 pages

Interleukin 10 Receptor (IL10R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 10 Receptor (IL10R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 10 Receptor (IL10R) Drugs in Development by T...

May 2022 42 pages

Interleukin 12 (IL12) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 12 (IL12) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 12 (IL12) Drugs in Development by Therapy Areas and Ind...

May 2022 89 pages

Interleukin 12 Receptor (IL12R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 12 Receptor (IL12R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 12 Receptor (IL12R) Drugs in Development by T...

May 2022 52 pages

Interleukin 13 (IL13) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 13 (IL13) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 13 (IL13) Drugs in Development by Therapy Areas and Ind...

May 2022 40 pages

Interleukin 15 (IL15) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 15 (IL15) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 15 (IL15) Drugs in Development by Therapy Areas and Ind...

May 2022 62 pages

Interleukin 15 Receptor Subunit Alpha (CD215 or IL15RA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 15 Receptor Subunit Alpha (CD215 or IL15RA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 15 Receptor Subunit A...

May 2022 62 pages

Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen 8 or CTLA8 or IL17A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen 8 or CTLA8 or IL17A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleuk...

May 2022 57 pages

Interleukin 17F (Cytokine ML 1 or IL17F) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 17F (Cytokine ML 1 or IL17F) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 17F (Cytokine ML 1 or IL17F) Drugs i...

May 2022 37 pages

Interleukin 18 (Interferon Gamma Inducing Factor or Iboctadekin or Interleukin 1 Gamma or IL18) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 18 (Interferon Gamma Inducing Factor or Iboctadekin or Interleukin 1 Gamma or IL18) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players S...

May 2022 37 pages

Interleukin 2 Receptor (IL2R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Interleukin 2 Receptor (IL2R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 2 Receptor (IL2R) Drugs in Development by Thera...

May 2022 134 pages

Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 2...

May 2022 46 pages

Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 2 (T Cell Growth F...

May 2022 55 pages

Interleukin 21 Receptor (Novel Interleukin Receptor or CD360 or IL21R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 21 Receptor (Novel Interleukin Receptor or CD360 or IL21R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 21 Rec...

May 2022 39 pages

Interleukin 22 Receptor (IL22R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 22 Receptor (IL22R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 22 Receptor (IL22R) Drugs in Development by T...

May 2022 39 pages

Interleukin 23 (IL23) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 23 (IL23) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 23 (IL23) Drugs in Development by Therapy Areas and Ind...

May 2022 61 pages

Interleukin 23 Receptor (IL23R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 23 Receptor (IL23R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 23 Receptor (IL23R) Drugs in Development by T...

May 2022 36 pages

Interleukin 23 Subunit Alpha (Interleukin 23 Subunit p19 or IL23A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 23 Subunit Alpha (Interleukin 23 Subunit p19 or IL23A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 23 Subunit...

May 2022 52 pages

Interleukin 4 (B Cell Stimulatory Factor 1 or Binetrakin or Lymphocyte Stimulatory Factor 1 or Pitrakinra or IL4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 4 (B Cell Stimulatory Factor 1 or Binetrakin or Lymphocyte Stimulatory Factor 1 or Pitrakinra or IL4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type...

May 2022 35 pages

Interleukin 4 Receptor Subunit Alpha (CD124 or IL4R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 4 Receptor Subunit Alpha (CD124 or IL4R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 4 Receptor Subunit Alpha...

May 2022 50 pages

Interleukin 5 (Eosinophil Differentiation Factor or B Cell Differentiation Factor I or T Cell Replacing Factor or IL5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 5 (Eosinophil Differentiation Factor or B Cell Differentiation Factor I or T Cell Replacing Factor or IL5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule...

May 2022 36 pages

Interleukin 6 Receptor (IL6R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 6 Receptor (IL6R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 6 Receptor (IL6R) Drugs in Development by Thera...

May 2022 63 pages

Interleukin 7 (IL7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 7 (IL7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 7 (IL7) Drugs in Development by Therapy Areas and Indicat...

May 2022 36 pages

Intermediate Conductance Calcium Activated Potassium Channel Protein 4 (KCa3.1 or Gardos Channel or KCNN4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Intermediate Conductance Calcium Activated Potassium Channel Protein 4 (KCa3.1 or Gardos Channel or KCNN4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Ke...

May 2022 40 pages

Intermediate Uveitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Intermediate Uveitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Intermediate Uveitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke...

May 2022 37 pages

Interstitial Cystitis (Painful Bladder Syndrome-Bladder Pain Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Interstitial Cystitis (Painful Bladder Syndrome-Bladder Pain Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Interstitial Cystitis (Painful Bladder Sy...

May 2022 49 pages

Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Interstitial Lung Diseases (Diffuse Parenchymal Lu...

May 2022 56 pages

Interstitial Lung Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Interstitial Lung Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Interstitial Lung Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule...

May 2022 40 pages

Intracerebral Hemorrhage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Intracerebral Hemorrhage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Intracerebral Hemorrhage Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...

May 2022 45 pages

Ischemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Ischemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Ischemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an ov...

May 2022 113 pages

Ischemic Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Ischemic Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Ischemic Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 40 pages

Ischemic Stroke Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Ischemic Stroke Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Ischemic Stroke Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 216 pages

Filters

Search

Categories

836
28
208
156
143
133
127
93
65,439
803
718
772
123

Publishers

179
1
239
158
389
103
444
148
425
3
202
3
6
1,620
487
76
123
208
111
25
212
1,049
378
23
40
68
472
277
34
29,954
248
501
3,036
1
1
2
3
16
536
361
1
1,357
1,790
60
1,696
8
8,921
2,212
4,495
321
66
3
36
200
29
29
143
42
83
3
281
85
20
6
43
14
1
178
48
359
36
44
10
11
18
168
323
8
3
18
58
901
6
89
12
24
15
1,285
227
128
386
3
74
10
119
228
46
474
26
133
4

Regions

92
58
45
43
41
35
31
30
30
29
28
28
28
26
16
16
14
12
12
10
10
10
9
8
8
8
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
790
495
2
2
2
117
194
102
53
23
704
26
136
526
174
623
64,568

Price

Date

Pages

Offers

1
280
1
1